Buprenorphine transdermal skin patch and Xpovio (100 MG Once Weekly)
Determining the interaction of Buprenorphine transdermal skin patch and Xpovio (100 MG Once Weekly) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: buprenorphine
Brand name: Probuphine, Belbuca, Buprenex, Butrans, Sublocade, Subutex
Synonyms: Buprenorphine (implant), Buprenorphine
Generic Name: selinexor
Brand name: Xpovio
Synonyms: Xpovio
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Buprenorphine transdermal skin patch-Xpovio (60 MG Once Weekly)
- Buprenorphine transdermal skin patch-Xpovio (80 MG Once Weekly)
- Buprenorphine transdermal skin patch-Xpovio (80 MG Twice Weekly)
- Buprenorphine transdermal skin patch-Xryliderm
- Buprenorphine transdermal skin patch-Xrylix
- Buprenorphine transdermal skin patch-Xtampza ER
- Xpovio (100 MG Once Weekly)-Buprenorphine, Buprenorphine Hydrochloride
- Xpovio (100 MG Once Weekly)-Buprenorphine/naloxone Oromucosal, Sublingual
- Xpovio (100 MG Once Weekly)-Buproban
- Xpovio (100 MG Once Weekly)-Bupropion
- Xpovio (100 MG Once Weekly)-Bupropion and naltrexone
- Xpovio (100 MG Once Weekly)-Bupropion Extended-Release Tablets